Large-scale ex vivo generation of human neutrophils from cord blood CD34+ cells

Loading...
Thumbnail Image

Authors

Jie, Zhenwang
Zhang, Yu
Wang, Chen
Shen, Bin
Guan, Xin
Ren, Zhihua
Ding, Xinxin
Dai, Wei
Jiang, Yongping

Issue Date

2017-07-11

Type

Article

Language

en_US

Keywords

antigens , CD34+ , cell differentiation , fetal blood , hematopoietic stem cells (HSCs) , neutrophils , umbilical cord blood (UCB) , neutropenia

Research Projects

Organizational Units

Journal Issue

Alternative Title

PLoS ONE

Abstract

Conventional high-dose chemotherapy frequently leads to severe neutropenia, during which patients experience a high risk of infection. Although support care with donor’s neutrophils is possible this choice is largely hampered by the limited availability of matched donors. To overcome this problem, we explored a large-scale ex vivo production of neutrophils from hematopoietic stem cells (HSCs) using a four-stage culture approach in a roller-bottle production platform. We expanded CD34+ HSCs isolated from umbilical cord blood (UCB) using our in-house special medium supplemented with cytokine cocktails and achieved about 49000-fold expansion of cells, among which about 61% were differentiated mature neutrophils. Ex vivo differentiated neutrophils exhibited a chemotactic activity similar to those from healthy donors and were capable of killing E. coli in vitro. The expansion yield as reported herein was at least 5 times higher than any other methods reported in the literature. Moreover, the cost of our modified medium was only a small fraction (<1/60) of the StemSpan™ SFEM. Therefore, our ex vivo expansion platform, coupled with a low cost of stem cell culture due to the use of a modified medium, makes large-scale manufacturing neutrophils possible, which should be able to greatly ameliorate neutrophil shortage for transfusion in the clinic.

Description

Citation

Jie, Z., Zhang, Y., Wang, C., Shen, B., Guan, X., Ren, Z., . . . Jiang, Y. (2017). Largescale ex vivo generation of human neutrophils from cord blood CD34+ cells. PLoS ONE, 12(7), 1-18. doi:10.1371/journal.pone.0180832

Publisher

PLoS ONE

License

Journal

Volume

Issue

PubMed ID

DOI

ISSN

1932-6203

EISSN